DNMR RSI Chart
Last 7 days
-1.2%
Last 90 days
-8.1%
Trailing 12 Months
-73.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 45.0M | 0 | 0 | 0 |
2023 | 50.4M | 50.6M | 51.1M | 46.7M |
2022 | 60.3M | 58.5M | 55.6M | 53.2M |
2021 | 49.9M | 52.5M | 53.0M | 58.7M |
2020 | 36.1M | 39.8M | 43.6M | 47.3M |
2019 | 0 | 0 | 0 | 32.3M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 07, 2024 | hajost michael a | acquired | - | - | 34,364 | chief financial officer |
Feb 07, 2024 | hajost michael a | sold (taxes) | -7,970 | 0.66 | -12,076 | chief financial officer |
Dec 29, 2023 | van trump phillip d | sold (taxes) | -19,304 | 1.02 | -18,926 | chief technology officer |
Dec 29, 2023 | tuten scott | sold (taxes) | -19,304 | 1.02 | -18,926 | chief marketing officer |
Dec 29, 2023 | smith michael eric | sold (taxes) | -28,925 | 1.02 | -28,358 | chief operating officer |
Nov 28, 2023 | hendrix richard j | bought | 46,480 | 0.9296 | 50,000 | - |
Nov 28, 2023 | hendrix richard j | bought | 46,915 | 0.9383 | 50,000 | - |
Jun 20, 2023 | tuten scott | sold | -27,390 | 2.739 | -10,000 | chief marketing officer |
May 17, 2023 | tuten scott | sold | -33,810 | 3.381 | -10,000 | chief marketing officer |
Apr 17, 2023 | tuten scott | sold | -42,619 | 4.2619 | -10,000 | chief marketing officer |
Which funds bought or sold DNMR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 10, 2024 | BlackRock Inc. | reduced | -3.7 | 185,354 | 6,558,910 | -% |
May 10, 2024 | CIBC Private Wealth Group, LLC | new | - | 368 | 368 | -% |
May 10, 2024 | LPL Financial LLC | added | 33.6 | 65,258 | 217,860 | -% |
May 10, 2024 | VANGUARD GROUP INC | added | 0.99 | 405,816 | 5,526,380 | -% |
May 10, 2024 | JPMORGAN CHASE & CO | reduced | -35.49 | -18,205 | 40,405 | -% |
May 10, 2024 | OSAIC HOLDINGS, INC. | reduced | -9.85 | -1,516 | 39,948 | -% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | added | 12.63 | 7,038 | 41,616 | -% |
May 10, 2024 | DIMENSIONAL FUND ADVISORS LP | unchanged | - | 2,622 | 40,835 | -% |
May 10, 2024 | PNC Financial Services Group, Inc. | unchanged | - | 1,452 | 22,628 | -% |
May 10, 2024 | CITIGROUP INC | added | 59.51 | 9,628 | 23,293 | -% |
Unveiling Danimer Scientific's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Danimer Scientific)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
APD | 55.7B | 12.2B | 22.55 | 4.58 | ||||
DOW | 41.8B | 43.5B | 32.96 | 0.96 | ||||
CE | 17.5B | 10.7B | 8.8 | 1.64 | ||||
AVTR | 16.5B | 6.9B | 63.46 | 2.4 | ||||
ALB | 15.5B | 8.4B | 45.82 | 1.84 | ||||
EMN | 11.9B | 9.1B | 12.85 | 1.31 | ||||
MID-CAP | ||||||||
CBT | 5.6B | 3.9B | 12.64 | 1.44 | ||||
BCPC | 5.0B | 929.6M | 43.62 | 5.39 | ||||
AVNT | 4.2B | 3.1B | 39.55 | 1.33 | ||||
ARCH | 2.9B | 3.0B | 9.05 | 0.98 | ||||
SMALL-CAP | ||||||||
CCF | 1.2B | 404.0M | 36.59 | 3 | ||||
ASIX | 671.5M | 1.5B | 295.44 | 0.46 | ||||
CMT | 179.8M | 336.4M | 9.86 | 0.53 | ||||
AREC | 104.5M | 16.7M | -8.83 | 6.24 | ||||
AMRS | 3.7M | - | -0.01 | 0.01 |
Danimer Scientific News
Income Statement (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Revenue | -6.6% | 10,224,000 | 10,945,000 | 10,948,000 | 12,865,000 | 11,926,000 | 15,324,000 | 10,448,000 | 12,703,000 | 14,743,000 | 17,728,000 | 13,369,000 | 14,471,000 | 13,181,000 | 12,027,000 | 12,835,000 | 11,873,000 | 10,598,000 | - |
Cost Of Revenue | -4.5% | 16,535,000 | 17,317,000 | 18,685,000 | 19,433,000 | 18,209,000 | 18,078,000 | 14,503,000 | 14,934,000 | 16,065,000 | 20,079,000 | 13,601,000 | 12,460,000 | 11,725,000 | 10,818,000 | 9,188,000 | 8,441,000 | 7,429,000 | - |
Costs and Expenses | -31.5% | 28,746,000 | 41,977,000 | 42,187,000 | 43,986,000 | 44,153,000 | 45,043,000 | 105,354,000 | 44,823,000 | 45,432,000 | 53,007,000 | 45,203,000 | 35,547,000 | 24,464,000 | 23,269,000 | 14,748,000 | 13,388,000 | 11,656,000 | - |
S&GA Expenses | -59.3% | 6,869,000 | 16,885,000 | 16,555,000 | 16,844,000 | 18,699,000 | 19,256,000 | 19,413,000 | 20,975,000 | 22,236,000 | 24,213,000 | 26,592,000 | 19,079,000 | 10,120,000 | 10,165,000 | 3,370,000 | 2,828,000 | 2,980,000 | - |
R&D Expenses | -29.5% | 5,342,000 | 7,575,000 | 6,883,000 | 7,709,000 | 7,075,000 | 7,709,000 | 7,947,000 | 8,913,000 | 7,131,000 | 8,666,000 | 5,010,000 | 3,975,000 | 2,619,000 | 2,286,000 | 2,190,000 | 2,128,000 | 1,247,000 | - |
EBITDA Margin | -1.1% | -3.37 | -3.33 | -2.65 | -3.66 | -3.39 | -3.04 | -2.75 | -1.06 | 0.11 | -1.06 | -1.06 | -1.08 | -1.98 | - | - | - | - | - |
Interest Expenses | -3.9% | -8,838,000 | -8,509,000 | -8,584,000 | -9,162,000 | -3,386,000 | 474,000 | -553,000 | -652,000 | -992,000 | -1,278,500 | 164,000 | 203,000 | 148,000 | -3,511,000 | 334,000 | 384,000 | 713,000 | - |
Income Taxes | -85.7% | 2,000 | 14,000 | 500,000 | -100,000 | -90,000 | -63,000 | -236,000 | -200,000 | -291,000 | -1,810,000 | -11,423,000 | - | - | - | - | - | - | - |
Earnings Before Taxes | 30.9% | -27,261,000 | -39,432,000 | -39,691,000 | -39,302,000 | -36,729,000 | -28,094,000 | -95,112,000 | -30,685,000 | -26,677,000 | -14,256,000 | -3,598,000 | 39,248,000 | -94,734,000 | -3,233,000 | -2,139,000 | -1,800,000 | -1,681,000 | - |
EBT Margin | 2.5% | -3.24 | -3.32 | -2.82 | -3.94 | -3.78 | -3.39 | -3.00 | -1.28 | -0.09 | -1.25 | -1.17 | -1.16 | -2.04 | - | - | - | - | - |
Net Income | 30.9% | -27,263,000 | -39,434,000 | -40,159,000 | -39,241,000 | -36,639,000 | -28,051,000 | -94,876,000 | -30,445,000 | -26,386,000 | -12,446,000 | 7,825,000 | 39,248,000 | -94,734,000 | -3,233,000 | -2,139,000 | -1,800,000 | -1,681,000 | - |
Net Income Margin | 2.5% | -3.25 | -3.33 | -2.82 | -3.93 | -3.77 | -3.38 | -2.95 | -1.05 | 0.14 | -1.02 | -0.96 | -1.16 | -2.04 | - | - | - | - | - |
Free Cashflow | 16.4% | -14,961,000 | -17,896,000 | -12,861,000 | -21,927,000 | -22,265,000 | -35,109,000 | -44,971,000 | -69,736,000 | -76,507,000 | -104,135,000 | -69,692,000 | -36,446,000 | -38,101,000 | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Assets | -1.3% | 689 | 698 | 721 | 744 | 779 | 712 | 733 | 791 | 812 | 839 | 650 | 646 | 512 | 546 | 202 | 202 | 145 |
Current Assets | -3.0% | 105 | 108 | 127 | 145 | 178 | 125 | 163 | 202 | 267 | 340 | 239 | 452 | 346 | 402 | 2.00 | 2.00 | 19.00 |
Cash Equivalents | 21.0% | 72.00 | 59.00 | 77.00 | 91.00 | 102 | 63.00 | 101 | 141 | 211 | 287 | 196 | 417 | 10.00 | 380 | 6.00 | 8.00 | 6.00 |
Inventory | 2.8% | 26.00 | 25.00 | 27.00 | 30.00 | 32.00 | 33.00 | 35.00 | 33.00 | 28.00 | 25.00 | 24.00 | 18.00 | 17.00 | 14.00 | - | - | 7.00 |
Net PPE | -1.2% | 440 | 445 | 450 | 454 | 455 | 454 | 437 | 409 | 365 | 316 | 223 | 160 | 130 | 107 | - | - | 72.00 |
Goodwill | - | - | - | - | - | - | - | - | 63.00 | 63.00 | 63.00 | 67.00 | - | - | - | - | - | - |
Liabilities | 3.0% | 433 | 420 | 417 | 414 | 423 | 335 | 342 | 319 | 325 | 338 | 121 | 139 | 230 | 190 | 169 | 149 | 128 |
Current Liabilities | 2.0% | 16.00 | 16.00 | 15.00 | 15.00 | 25.00 | 25.00 | 32.00 | 31.00 | 35.00 | 43.00 | 32.00 | 29.00 | 24.00 | 50.00 | 0.00 | 0.00 | 34.00 |
LT Debt, Current | -42.5% | 1.00 | 1.00 | 1.00 | 2.00 | 7.00 | 2.00 | 2.00 | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25.00 | - | - | 9.00 |
Shareholder's Equity | -7.9% | 256 | 278 | 304 | 705 | 691 | 378 | 392 | 0.00 | 488 | 0.00 | 529 | 0.00 | 282 | 0.00 | 42.00 | 38.00 | 17.00 |
Retained Earnings | -6.0% | -481 | -454 | -414 | -374 | -335 | -298 | -270 | -175 | -145 | -118 | -106 | -114 | -153 | -58.78 | -0.24 | -0.09 | -49.93 |
Additional Paid-In Capital | 0.7% | 737 | 732 | 719 | 705 | 691 | 676 | 662 | 648 | 633 | 619 | 636 | 621 | 436 | 415 | 5.00 | 5.00 | 67.00 |
Shares Outstanding | 11.1% | 114 | 103 | 102 | 102 | 102 | 102 | 101 | 101 | 101 | 101 | 100 | 98.00 | 85.00 | - | - | - | - |
Float | - | - | - | - | 243 | - | - | - | 461 | - | - | - | 2,198 | - | - | - | 196 | - |
Cashflow (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Cashflow From Operations | 18.5% | -12,991 | -15,933 | -10,180 | -15,286 | -5,865 | -4,255 | -20,189 | -19,788 | -17,605 | -15,522 | -24,800 | -8,433 | -14,208 | -3,382 | -26.00 | -4,774 | -5,615 | - |
Share Based Compensation | -96.9% | 574 | 18,635 | 4,600 | 13,909 | 14,065 | 24,234 | 4,700 | 4,600 | 13,750 | 25,958 | 4,800 | 14,031 | 4,700 | 3,122 | 221 | 155 | 147 | - |
Cashflow From Investing | -0.6% | -1,970 | -1,959 | -2,663 | -6,641 | -16,400 | -30,854 | -42,819 | -49,893 | -58,916 | -88,531 | -196,071 | -27,673 | -23,893 | -13,090 | -6,099 | -3,730 | -15,340 | - |
Cashflow From Financing | 2946.5% | 13,037 | -458 | -541 | -6,510 | 91,539 | -1,280 | 22,961 | -7.00 | 78.00 | 194,724 | 289 | 137,755 | -26,566 | 390,219 | 4,263 | 1,182 | 27,011 | - |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 152 | - | - | - |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue: | ||
Total revenue | $ 10,224 | $ 11,926 |
Costs and expenses: | ||
Cost of revenue | 16,535 | 18,209 |
Selling, general and administrative | 6,869 | 18,699 |
Research and development | 5,342 | 7,075 |
Loss on sale of assets | 0 | 170 |
Total costs and expenses | 28,746 | 44,153 |
Loss from operations | (18,522) | (32,227) |
Nonoperating income (expense): | ||
Gain (loss) on remeasurement of warrants | 99 | (1,116) |
Interest, net | (8,838) | (3,386) |
Total nonoperating expense: | (8,739) | (4,502) |
Loss before income taxes | (27,261) | (36,729) |
Income taxes | (2) | 90 |
Net loss | $ (27,263) | $ (36,639) |
Net loss per share: | ||
Basic net loss per share | $ (0.26) | $ (0.36) |
Diluted net loss per share | $ (0.26) | $ (0.36) |
Basic - Weighted Average Number Of Shares Outstanding | 103,968,384 | 101,896,326 |
Diluted - Weighted Average Number Of Shares Outstanding | 103,968,384 | 101,896,326 |
Products | ||
Revenue: | ||
Total revenue | $ 9,955 | $ 11,096 |
Services | ||
Revenue: | ||
Total revenue | $ 269 | $ 830 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 57,341 | $ 59,170 |
Accounts receivable, net | 12,233 | 15,227 |
Other receivables, net | 682 | 652 |
Inventories, net | 25,989 | 25,270 |
Prepaid expenses and other current assets | 5,492 | 4,714 |
Contract assets, net | 3,028 | 3,005 |
Total current assets | 104,765 | 108,038 |
Property, plant and equipment, net | 439,834 | 445,153 |
Intangible assets, net | 77,169 | 77,790 |
Right-of-use assets | 19,162 | 19,160 |
Leverage loans receivable | 31,446 | 31,446 |
Restricted cash | 14,239 | 14,334 |
Other assets | 2,310 | 2,210 |
Total assets | 688,925 | 698,131 |
Current liabilities: | ||
Accounts payable | 3,884 | 5,292 |
Accrued liabilities | 6,484 | 4,726 |
Unearned revenue and contract liabilities | 1,154 | 1,000 |
Current portion of lease liability | 3,722 | 3,337 |
Current portion of long-term debt, net | 787 | 1,368 |
Total current liabilities | 16,031 | 15,723 |
Long-term lease liability, net | 21,502 | 21,927 |
Long-term debt, net | 384,229 | 381,436 |
Warrants liability | 9,656 | 5 |
Other long-term liabilities | 1,414 | 1,020 |
Total liabilities | 432,832 | 420,111 |
Commitments and contingencies (Note 14) | ||
Stockholders’ equity: | ||
Common stock, $0.0001 par value; 200,000,000 shares authorized: 114,240,921 and 102,832,103 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 12 | 10 |
Additional paid-in capital | 737,465 | 732,131 |
Accumulated deficit | (481,384) | (454,121) |
Total stockholders’ equity | 256,093 | 278,020 |
Total liabilities and stockholders’ equity | $ 688,925 | $ 698,131 |